Octreotide and Insulin Degludec Interaction
Drug interaction information between Octreotide and Insulin Degludec.
Octreotide and Insulin Degludec have a documented moderate interaction in FDA labeling.
FDA drug labeling documents a moderate-severity interaction between Octreotide and Insulin Degludec. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.
How They Interact
This medication can make your body more sensitive to insulin, which increases the risk of having low blood sugar.
FDA Label Information
Drugs That May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics Intervention: Dosage reductions and increased frequency of glucose monitoring may be required when XULTOPHY 100/3.6 is coadministered with these drugs.
Octreotide Also Interacts With
- Insulin Aspart moderate
- Insulin Detemir moderate
- Insulin Glargine moderate
- Insulin Glulisine moderate
- Insulin Human/Insulin Isophane moderate
Insulin Degludec Also Interacts With
- Fluoxetine moderate
- Liraglutide moderate
- Pramlintide moderate
- Albuterol minor
- Clonidine minor
Frequently Asked Questions
What SPL severity band is on file for Octreotide + Insulin Degludec?
Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.
Which drug in this pair has the larger labeled-interaction portfolio?
Octreotide has 14 labeled pairs on file vs Insulin Degludec's 12. In the moderate band specifically: Octreotide has 9 (also Insulin Aspart, Insulin Detemir, Insulin Glargine, Insulin Glulisine); Insulin Degludec has 4 (also Fluoxetine, Liraglutide, Pramlintide).
What mechanism field is on file for Octreotide and Insulin Degludec?
This medication can make your body more sensitive to insulin, which increases the risk of having low blood sugar.
Octreotide's labeled portfolio outnumbers Insulin Degludec
SPL source-record counts only. This page's band is moderate · classes on file: Octreotide (Somatostatin Analog); Insulin Degludec (Ultra-Long-Acting Insulin).
0 major · 9 moderate · 5 minor · 14 total
- Other moderate peers for Octreotide
- Insulin Aspart
- Insulin Detemir
- Insulin Glargine
- Insulin Glulisine
0 major · 4 moderate · 8 minor · 12 total
- Other moderate peers for Insulin Degludec
- Fluoxetine
- Liraglutide
- Pramlintide
Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.
Read our methodology - how this data is sourced, computed, and verified.